Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vera Therapeutics, Inc.

22.65
-0.6400-2.75%
Post-market: 22.650.00000.00%19:15 EDT
Volume:2.68M
Turnover:61.08M
Market Cap:1.44B
PE:-7.55
High:23.38
Open:23.19
Low:22.28
Close:23.29
Loading ...

Director Patrick G. Enright Reports Acquisition of Common Shares in Vera Therapeutics Inc

Reuters
·
26 Jun

Vera Therapeutics Inc put volume heavy and directionally bearish

TIPRANKS
·
17 Jun

Vera Therapeutics Inc : JP Morgan Cuts Target Price to $56 From $68

THOMSON REUTERS
·
13 Jun

Vera Therapeutics Inc call volume above normal and directionally bullish

TIPRANKS
·
11 Jun

VERA and cheqd to launch secure messaging for business, powered by blockchain 4 minutes ago

cryptonews
·
10 Jun

BRIEF-Vera Therapeutics reports inducement grants under Nasdaq listing rule

Reuters
·
10 Jun

Vera Therapeutics Announces Inducement Grants for New Employees Under Nasdaq Rule, Featuring Stock Options and RSUs

Reuters
·
10 Jun

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
10 Jun

Wedbush Keeps Their Hold Rating on Vera Therapeutics (VERA)

TIPRANKS
·
09 Jun

Wedbush Cuts Price Target on Vera Therapeutics to $23 From $32, Keeps Neutral Rating

MT Newswires Live
·
09 Jun

Guggenheim Reaffirms Their Buy Rating on Vera Therapeutics (VERA)

TIPRANKS
·
07 Jun

Vera Therapeutics (VERA) Gets a Buy from Evercore ISI

TIPRANKS
·
07 Jun

BUZZ-U.S. STOCKS ON THE MOVE-WEC Energy, FuelCell Energy, Phathom Pharma

Reuters
·
07 Jun

Vera Therapeutics Down Over 28%, on Track for Largest Percent Decrease Since January 2023 -- Data Talk

Dow Jones
·
07 Jun

Crude Oil Gains 2%; ABM Industries Shares Plunge After Q2 Results

Benzinga
·
07 Jun

Biotech Stock Vera Is Slumping After Monster Gain -- Barrons.com

Dow Jones
·
06 Jun

Vera Therapeutics Shares Down 31.4% After Rival Otsuka's Kidney Disease Drug Succeeds in Late-Stage Trial

THOMSON REUTERS
·
06 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Omada Health, Sandisk, Manchester United

Reuters
·
06 Jun

Vera Therapeutics drops 30% after rival Otsuka presents Phase 3 data

TIPRANKS
·
06 Jun

Buy Rating for Vera Therapeutics: Promising Atacicept Data and Market Potential in IgAN Treatment

TIPRANKS
·
06 Jun